PONV Pressure Point Therapy-Juniper Publishers


Juniper Publishers-Journal of Anesthesia

News

Pressure Point, Inc. is a global medical device company specializing in mainstream acu-point stimulation strips, which improve multi-modal anesthetic techniques associated with the complexity common problem of post-operative nausea and vomiting. The company introduced its Pressure Right© acupressure point-stimulation product in 2011 after receiving market clearance from the FDA as a prescribed technique representing an essential part of the anesthetic plan for surgery patients. In 2014, Pressure Point subsequently received market clearance as an OTC technique for the prevention of nausea and vomiting.
As part of a multi-modal strategy for patients undergoing laparoscopic surgery, a double-blind, sham-controlled study reported that the use of Pressure Right© demonstrated a statistically meaningful, absolute risk reduction of PONV for surgical patients as long as 72 hours postoperatively. The study further confirmed the direct result of prophylaxis with Pressure Right© revealed a multi-modal PONV effect to substantially reduce the main stream requirements for expensive rescue-drug therapies. As a result, a broader patient satisfaction with PONV prevention was reported among Pressure Right© study subjects.
Prior to the introduction of the multi-modal Pressure Right© acu-stimulation strip in 2011 for the 72-hour prevention of PONV, a plethora of research had been published on the efficacy of acu-stimulation for PONV. Several incipient versions of acu-stimulation offered significant benefits and few, if any risks. However, the early product models were limited in duration for multi-modal nausea prophylaxis for surgical use and patient suitability for PONV prevention.

Outside the US today, Pressure Point© has overseas distribution partners targeting the anesthetic market for prevention of PONV for at-risk surgical patients. Research and expanding use has proven Pressure Right© to be a safe choice in PONV management. The corporate mission for the product is hope and effectiveness to bring maximum efficacy of clinical multi-modal PONV therapy to finally provide surgical patients freedom from anesthetic-related nausea and vomiting complications.

For more Open Access Journals in Juniper Publishers please click on: https://juniperpublishers.com



Comments

Post a Comment

Popular posts from this blog

Tourniquet Pain after Ultrasound-Guided Axillary Blockade-Juniper Publishers

Image
Juniper Publishers - Journal of Anesthesia Abstract Objective: To analyse tourniquet pain after ultrasound guided axillary block (AXB) as the sole anesthetic technique with no injection of local anaesthetic into the subcutaneous tissue of the posterior half of the axilla to prevent tourniquet pain. Material/patients and methods: 84 patients older than 18 years ASA I-IV undergoing surgery at hand, wrist, forearm and elbow under ultrasound guided AXB requiring upper arm tourniquet, we studied prospectively. Exclusion criteria included refusal to participate, communication problems, pre-existing neuropathy, coagulopathy or allergy to local anaesthetics. Tourniquet pain was assessed according to visual analogue scale (VAS) every 15 minutes. We also analysed differences in tourniquet pain between sedated and non-sedated patients. Main results: VAS was 0 during ischemia in 83 patients. One patient reported tourniquet pain. This was mild (VAS = 3) and reported duri...
Read more

Heerfordt's Syndrome: A New Atypical Clinical Presentation-Juniper Publishers

Image
Juniper Publishers - Journal of Anesthesia Abstract Heerfordt’s syndrome is an unusual clinical manifestation (less than 5%) of sarcoidosis, characterized by parotitis, uveitis, and peripheral facial palsy, febrile syndrome is usually associated. Oral corticosteroid is the treatment of choice. We report a case of a patient in which the syndrome of Heerfordt was retained. Keywords: Heerfordt’s syndrome, parotitis, uveitis, sarcoidosis, facial palsy. Introduction The sarcoidosis is a systemic granulomatosis of unknown cause, characterized by its clinical polymorphism and a wide variety of its modes of presentation. The combination of fever, uveitis, parotitis and peripheral facial paralysis defines Heerfordt’s syndrome which presents an unusual manifestation of this disease. We report a case of a patient in which the syndrome of Heerfordt was found. Case Report A 49 year-old female followed i...
Read more